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http://dx.doi.org/10.1016/j.jmii.2014
1684-1182/Copyright ª 2014, TaiwanThis study was designed to investigate the in vitro anticandidal activity of some medicinal
plants and Pseudomonas aeruginosa strains against Candida species. The antifungal activity
of methanolic extracts of five medicinal plants, namely, Cinnamomum porrectum, Lippia nu-
diflora, Cestrum nocturnum, Trachyspermum ammi, and Sida carpinifolia were studied. The
medicinal characteristics of these plants were compared with commercially used antibiotics.
The antimicrobial assay was done by agar well diffusion and the broth dilution method. Among
the plants used, T. ammi and C. nocturnum were found to be more potent than the others.
Twenty P. aeruginosa strains were isolated from various clinical specimens. The total inhibi-
tions obtained were found to be 47%, 38%, and 36% in blood agar, whereas in Sabouraud
dextrose agar (SDA) the inhibitions were 57%, 48%, and 37%, respectively.
Copyright ª 2014, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Introduction
Northeast India has been identified as one of the biodiver-
sity hotspots among the 32 hotspots identified worldwide.1
The medicinal plants of this area are still to be identified
and studied properly. The objective of the present inves-
tigation is to screen medicinal plant species andt of Molecular Biology and
pur 784028, India.
il.com.
.10.002
Society of Microbiology. PublishePseudomonas aeruginosa strains isolated from patients at
the local civil hospital for antifungal activities against the
pathogenic microorganism Candida species, which inhabits
the gastrointestinal tract, buccopharyngeal cavity, and
vulvovaginal tract, is capable of causing serious systemic
infections, and is frequently associated with indwelling
catheters and immunosuppressive agents.2 Candida species
are also benign members of skin and mucosal flora. When
host defenses falter, however, Candida species initiate
invasive growth that can lead to severe diseases.
According to an National Nosocomial Infection Surveil-
lance (NNIS) survey from 1980 to 1990, the most frequentlyd by Elsevier Taiwan LLC. All rights reserved.
Anticandidal activity against Candida species 277isolated nosocomial fungal pathogen was Candida albicans
(59.77%) followed by other Candida species (18.6%). From
time immemorial, medicinal and aromatic plants have been
used to get relief from various ailments. The widespread
belief that green medicine is healthier than synthetic
products has revived the interest in natural drugs.
P. aeruginosa is a part of the human microflora of
healthy individuals. Because of the ingestion of the organ-
ism through the colonization respiratory tract, the bowel is
the most likely colonized site. The likelihood of coloniza-
tion increases with the longevity of hospitalization. Pseu-
domonads represent the major group of nondifferentiating
microorganisms that produce antibiotics. The antibiotic
substances are pyocyanin, pyrrolnitrin, and pseudomonic
acid. It has been demonstrated that some secondary me-
tabolites, production of phytotoxins, slime production,
production of antifungal compounds, produced by pseudo-
monads, give an obvious selective advantage to these or-
ganisms in their natural environment.3,4
This study investigated the in vitro efficacy of some
medicinal plants and P. aeruginosa strains against Candida
species.
Materials and methods
Plant material
Five medicinal plants were chosen for this study. The plant
materials (leaves, fruits, and seeds) were collected from
Tezpur (border of Northeastern India). The plant materials
collected were brought to the laboratory in polythene bags,
identified by experts of the institute, and processed. Fresh
plant materials were washed under running water, shade
dried, homogenized to a fine powder, and processed
accordingly.
Microorganisms
Twenty P. aeruginosa isolates were isolated from the cul-
ture of patients of a local civil hospital. Each single isolate
was collected from different patients. The strains were
identified by standard bacterial identification methods.5 P.
aeruginosa isolates were identified on the basis of their
characteristic colony morphologies and the production of
diffusible pigments. P. aeruginosa strains were identified
based on the positive oxidase test, triple sugar ion reaction
of alkaline over no change, no growth at 42

C. The strains
of Candida including Candida krusei ATCC 6258, C. albi-
cans, and Candida tropicalis were the clinical isolates ob-
tained from the School of Tropical Medicine, Kolkata, India.
To investigate the in vitro anticandidal activity of P. aeru-
ginosa strains, the Kerrs method4 was taken into
consideration.
Preparation of the plant extract and test extracts
A total of 5 g of the material was extracted with 150 mL
methanol in Soxhlet apparatus. The solvent was evaporated
at room temperature and the extracts thus obtained were
stored in airtight bottles for further studies. Each extractwas dissolved in dimethyl sulfoxide at a concentration of
0.2 mg/mL and was used as working stock. Clotrimazole
1000 mg/mL was used as the standard for comparison.
Technique
The antifungal assay of the plant extracts was evaluated
employing an agar well diffusion method.6 Sterilized Sabo-
uraud dextrose agar (SDA) medium was poured into sterile
Petri plates and allowed to solidify. After solidification of
the medium, the broth was vortexed and 100 mL of the broth
was spread evenly over the surface of the agar plates. A well
of 8 mm diameter was made in each plate with a sterile cup
borer. Into each well was introduced 100 mL of the test
extract and the plates were incubated at 28

C for 24 hours.
The experiment was replicated three times. The efficacy
was determined by measuring the diameter of the inhibition
zone exhibited by the extracts against the test pathogen.
The minimal inhibitory concentrations (MICs) of the aqueous
plant extract as well as reference drugs against Candida
strains were determined by the broth dilution method.7
Activity index determination
The activity index of the extracts was determined by the
following formula provided by Jain and Sharma:8
Activity indexZ
Inhibition zone of extracts
Inhibition zone of standard
:
To investigate the in vitro anticandidal activity of P.
aeruginosa strains, the Kerrs method was employed. The
isolated P. aeruginosa strains were stored at þ4oC on the
nutrient agar slopes and Candida isolates were maintained
on SDA plates. The inoculums were prepared by fresh 24
hour plate cultures of each P. aeruginosa strain of 106 CFU/
mL in 0.08% NaCl to test the anticandidal activity. Freshly
prepared inoculum (20 mL) was streaked on SDA and blood
agar with a width of 1 cm across. Plates were then incu-
bated at 30

C for 24 hours. Further growth was removed
using a glass slide. Filter paper disks of 5 cm in diameter
were cut, soaked in chloroform, and laid on a metal tray in
a safety cabinet. Each plate was then placed face down on
the top of a chloroform-containing filter paper disk and was
left for 20 minutes so that the microscopic remnants of the
culture were killed. The plates were removed from the
cabinet, and traces of chloroform were eliminated by
exposure to air for few minutes. A fresh 24 hour plate
culture of each fungal strain was used to prepare an inoc-
ulum of 106 CFU/mL. This fungal suspension was streaked
onto the chloroform treated medium at right angles to the
line of the original medium: plates were then incubated for
24 hours at 30

C. Each of the 20 P. aeruginosa strains was
tested against each of the three Candida strains. Plates
were read as follows: total inhibition fungal growth was
recorded as (a  b) and no inhibition of fungal growth was
recorded as ().
Statistical analysis
The Chi-square test was used to compare in vitro anti-
candidal activity on blood agar and on SDA.
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278 L. BoraResults
In the present study, the extracts of five medicinal plants
were investigated for their antifungal activities against C.
albicans. The details of the results are shown in Table 1.
The study shows that all of the plant extracts are active
against the test pathogens, but the seeds extract of Tra-
chyspermum ammi and the leaf extract of Cestrum noc-
turnum exhibited more potent antifungal efficacy, showing
maximum inhibition zones of diameters 38.3 mm and
31.3 mm, respectively, against C. albicans (Table 1). The
leaf extract of Lippia nudiflora revealed less activity than
that of the standard. The activity index, as revealed in
Table 1, is at maximum in the seed extract of T. ammi
followed by C. nocturnum, while it is the least in the case
of L. nudiflora. The MICs of the potent plant extract,
nystatin, and clotrimazole are shown in Table 2. The effect
of the unrefined nature of the plant extract as compared to
the reference drugs is once more apparent. However, there
is obvious evidence that the plant extract has a substantial
level of anticandidal activity. Comparatively, the Candida
strains isolates seemed to be more sensitive to the plant
extract. It would appear that the strains were more resis-
tant to the plant extracts and nystatin than to clotrimazole.
P. aeruginosa strains were isolated from tracheal aspi-
ration materials, wound, and sputum. The anticandidal
activity of P. aeruginosa strains was determined in eight of
10 tracheal, three of six wound, and two of four sputum
sample isolates. All P. aeruginosa strains have pyocyanin
pigment.
The total inhibition rates were obtained using SDA for C.
albicans, C. tropicalis, and C. krusei and were 47%, 38%,
and 36%, respectively. When SDA was used, the rates were
detected as 57%, 48%, and 37%, respectively. There was no
significant difference between blood agar and SDA results
(p > 0.06) which demonstrates in vitro anticandidal activity
on the blood agar and SDA (Table 3).
Discussion
In recent years, there has been a gradual revival of interest
in the application of medicinal plants in developed, as well
as in developing, countries and the medicinal properties of
several plants have been explored. A successful search for
medicinal property of any plant largely depends on the
solvent utilized in the process of extraction. Most tradi-
tional practitioners use water as a solvent and are unable to
get the desired results.
Despite the striking success of the pharmaceutical in-
dustries in creating new antibiotics, finding new broad-
spectrum antimicrobial agents is still a priority because of
resistant bacterial infections.8 Antifungal agents currently
available in the market are limited due to their toxicity,
low effectiveness, and cost for prolonged treatment.
Therefore, there is a need to develop antifungal agents
which can satisfy the present scenario. The efficacies of
the extracts were also compared with the activity of the
standard antibiotic clotrimazole, available in the market.
The present results showed that, with the exception of one
(L. nudiflora), all of the extracts were more promising
than the standard antifungal. Significant differences are
Table 2 Minimum inhibitory concentrations (MIC) of potential plant extracts and standard antifungals against the test strains
Organisms Mean MIC (SD)
Cestrum nocturnum
mg/mL
Trachyspermum ammi
mg/mL
Nystatin
IU/mL
Clotrimazole
mg/mL
Candida albicans 20.44  0.45 26.44  1.41 30.33  2.02 10.08  2.45
Candida tropicalis 42.40  10.08 40.42  1.08 40.08  3.32 11.08  3.56
Candida krusei 38.68  11.18 41.08  1.34 40.44  2.28 12.08  3.38
SD Z standard deviation.
Table 3 Anticandidal activity of Pseudomonas aeruginosa strains on blood agar and on Sabouraud dextrose agar (SDA)
Organisms Blood agar SDA
Total inhibition
n (%)
Partial inhibition
n (%)
Total inhibition
n (%)
Partial inhibition
n (%)
Candida albicans 21 (47) 4 (8) 24 (57) 6 (14)
Candida tropicalis 18 (38) 9 (17) 21 (48) 8 (18)
Candida krusei 16 (36) 5 (9) 16 (37) 4 (10)
Anticandidal activity against Candida species 279normally observed when crude (unpurified) plant extracts
are compared with pure drugs.9 The agar-cup diffusion
method is commonly employed for preliminary suscepti-
bility testing, but it is not a dependable and accurate
method for comparison, because of the high degree of
interference due to drug diffusion problems.10 A more
generally accurate method of assessment is the broth
dilution technique. In this study, therefore, the broth
dilution method was used in determining the activities
measured as MIC. These observations point “to the fact
that in order to make” an affirmative conclusion on the
activity of a drug (especially a new product), strains of the
organisms from a wide variety of sources should be
employed at the evaluation stage.
The study was also designed to investigate the in vitro
anticandidal activity of P. aeruginosa strains against three
Candida species. The total inhibition rates obtained by
using blood agar suggested that C. albicans and C. tropi-
calis were the most inhibitive strains. C. krusei was found
to be the least inhibitive strain. There was no significant
difference between the blood agar and SDA results. The
total inhibition rates observed for C. albicans and C. krusei
were 10% and 6%, respectively, using blood agar.11 Our re-
sults are comparable with the results of Yucesoy et al11
because C. albicans is the most inhibitive strain and no
significant difference was detected on blood agar and SDA
results. However, their anticandidal activity rates reported
are less than ours. Different Pseudomonas species such as P.
aeruginosa, Pseudomonas flourescens, Pseudomonas mul-
tivorans, Pseudomonas aureofaciens, and Burkholderia
cepacia were implicated for antibiotic production in med-
ical literature. Total inhibition of Candida strains by 10 P.
aeruginosa strains was observed by Kerr.3 The complete
inhibition is due to the formation of pyocyanin, which is
known to reduce cyclic adenosine monophosphate (cAMP)
and adenosine triphosphate (ATP) in human epithelial cells
and is a possible explanation of increased antifungal ac-
tivity of pyocyanin against C. albicans in the well plate
assay.The growth of dermatophyte and non dermatophyte
fungi was found to be poor in the presence of P. aeruginosa
as observed by Foster et al5 and they also showed that large
P. aeruginosa populations in infected nails resulted in a
lower fungal population. It may interact with the endo-
thelium derived relaxing factor or nitric oxide through
formation of a complex, or it may act by nitric oxide syn-
thase. An elaborate study on the interaction of C. albicans
with Pseudomonas spp. in vitro showed that Pseudomonas
spp. forms biofilm on C. albicans cells and kills them.10 It
has been suggested that only the filamentous form of
C. albicans, not the yeast form, is affected by Pseudomonas
spp., because of the difference in their cell walls.
Several clinical reports have shown that the presence of
P. aeruginosa appears to limit the growth of C. albicans and
that attention of P. aeruginosa by treatment with antibi-
otics is often followed by the increase in the C. albicans
population. The interactions between fungi and bacteria in
natural settings are complicated by a number of factors
including the host response, environmental parameters,
and species composition of the community. The present
study reveals the potential of medicinal plants to be used as
antifungal agents and the potential of P. aeruginosa and its
compounds in the treatment of candidiasis.Conflicts of interest
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